Related Experiment Videos
The complications of intravenous Corynebacterium parvum infusion
Abstract:
100 intravenous infusions of Corynebacterium parvum were given to thirty-six patients at a dose of 5 mg/m2. Fever and rigors occurred in all patients but these acute side effects were acceptable to all but two patients. Seventeen patients suffered a delayed fall in blood pressure, which was marked in eight of them but was generally well tolerated. One patient died 18 hr after infusion from extensive myocardial infarction. Herpes labialis complicated the first infusion in nine instances, which may reflect transient immunosuppression following immunotherapy.
Insights
Corynebacterium parvum immunotherapy induced fever and rigors in all patients. While generally well-tolerated, delayed hypotension and herpes labialis were observed, indicating potential transient immunosuppression.
Area of Science:
- Immunotherapy
- Oncology
- Clinical Trials
Background:
- Corynebacterium parvum (C. parvum) is an immunomodulator used in cancer therapy.
- Understanding the safety and tolerability profile of C. parvum is crucial for its clinical application.
Purpose of the Study:
- To evaluate the safety and tolerability of intravenous Corynebacterium parvum in patients undergoing cancer immunotherapy.
- To document acute and delayed adverse events associated with C. parvum infusions.
Main Methods:
- 100 intravenous infusions of Corynebacterium parvum were administered to 36 patients at a dose of 5 mg/m2.
- Adverse events, including fever, rigors, blood pressure changes, and herpes labialis, were systematically recorded.
Main Results:
- All patients experienced fever and rigors, which were acceptable to most.
- Seventeen patients had delayed hypotension, severe in eight, but generally well-tolerated.
- Nine patients experienced herpes labialis after the first infusion, suggesting possible transient immunosuppression.
Conclusions:
- Intravenous Corynebacterium parvum immunotherapy is associated with acute side effects like fever and rigors.
- Delayed hypotension and herpes labialis are potential adverse events requiring monitoring.
- The observed side effects suggest a need for further investigation into the immunomodulatory effects of C. parvum.